Authors
Loading...
Untargeted metabolomics demonstrates predictive models for diagnosis and risk stratification in NKTCL patients, indicating precision medicine benefits.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: